XML 21 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 2 - Acquisition of Assets of M.C. Healthcare Products Inc.
12 Months Ended
Sep. 28, 2013
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block]

2. ACQUISITION OF M.C. HEALTHCARE PRODUCTS INC.


On December 9, 2011, we acquired, through a new wholly-owned subsidiary, substantially all of the assets of M.C. Healthcare Products Inc. (“Old M.C. Healthcare”) for approximately $9,800,000, including cash of approximately $7,980,000 at the time of closing and approximately $354,000 for the post-closing working capital adjustment, paid in January 2012, plus 100,000 shares of Span-America common stock valued at approximately $1,441,000. M.C. Healthcare manufactures medical bed frames and related products. We funded the acquisition through a combination of cash on hand, proceeds from the sale of securities available for sale and proceeds of approximately $6,500,000 from our revolving credit facility. No cash was acquired. The excess of the consideration transferred over the net tangible and intangible assets was reflected as goodwill of approximately $2,500,000.


The allocation of the total consideration to the fair value of the assets acquired and liabilities assumed in U.S. dollars as of December 9, 2011 was as follows:


Receivables

  $ 1,800,000  

Inventories

    2,210,000  

Intangibles

    3,980,000  

Other current assets

    60,000  

Equipment

    300,000  

Goodwill

    2,530,000  

Liabilities assumed

    (1,070,000 )

Contingent consideration

    (70,000 )

Deferred tax liability

    (50,000 )
    $ 9,690,000  

For the period from December 9, 2011, the date of the acquisition, through September 29, 2012, M.C. Healthcare contributed net revenues of approximately $10,284,000 and operating income of approximately $964,000. For fiscal year 2013 M.C. Healthcare contributed net revenues of approximately $11,305,000 and operating income of approximately $245,000. These results are included in the Consolidated Financial Statements.


Pro-forma information for the years ended September 29, 2012 and October 1, 2011 as if the purchase had occurred on October 2, 2010 are below. See Form 8-K/A filed on February 24, 2012 for additional information.


   

2012

   

2011

 

Pro-forma net revenues

  $ 78,540,000     $ 64,890,000  

Pro-forma net income

    5,350,000       4,770,000  

Pro-forma net income per diluted share

  $ 1.81     $ 1.62